Data / Form D filings / Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc.: Form D filings
Cyclacel Pharmaceuticals, Inc., a biotechnology company in Berkeley Heights, NJ, filed 8 Form D notices with the SEC between 2010 and 2025. The latest, on March 25, 2025, reports $1 million sold of a $1 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 CONNELL DRIVE, SUITE 1500, Berkeley Heights, NJ, 07922
- Phone
- (908) 517-7330
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1130166
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | New notice | $1,000,000 | $1,000,000 | 4 | Mar 21, 2025 | sec.gov | |
| Feb 14, 2025 | New notice | $25,000,000 | $0 | $25,000,000 | 1 | Yet to occur | sec.gov |
| Feb 14, 2025 | New notice | Indefinite | $0 | 1 | Feb 6, 2025 | sec.gov | |
| Nov 26, 2024 | New notice | $2,062,112 | $2,062,112 | 1 | Nov 14, 2024 | sec.gov | |
| May 17, 2024 | New notice | $8,000,000 | $8,000,000 | 1 | May 2, 2024 | sec.gov | |
| Jan 4, 2021 | New notice | $7,000,000 | $7,000,000 | 1 | Dec 18, 2020 | sec.gov | |
| May 1, 2012 | New notice | $3,036,000 | $3,036,000 | 7 | Mar 22, 2012 | sec.gov | |
| Oct 21, 2010 | New notice | $22,150,089 | $15,200,226 | $6,949,863 | 20 | Oct 7, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Avraham Fock Ben-Tzvi | Director | |
| Kiu Cu Seng | Executive Officer | |
| David Fock Natan | Director | |
| Kwang Fock Chong | Director | |
| Datuk Dr. Doris Wong Sing Ee | Executive Officer |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Mar 24, 2025 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cyclacel Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.